FTSE 100 movers: Sky gains on Comcast report; Babcock goes ex-div

Michele Maatouk WebFG News | 07 Dec, 2017 15:06 - Updated: 16:28 | | |

sky, bskyb

London’s FTSE 100 was down 0.3% to 7,329.93 in afternoon trade on Thursday.

Hammerson was clawing back some of its losses from Wednesday, when shares fell after it announced that it had agreed to buy rival Intu Properties in a £3.4bn all-share deal that will create a £21bn portfolio across Europe.

Sky gained following reports that Comcast Corp is interested in taking full control of the broadcaster and other assets of major shareholder 21st Century Fox, which is already in advanced sale talks with Disney.

Ashtead was up as Numis upgraded the stock to ‘buy’ from ‘add’ and lifted the price target to 2,500p from 2,000p, while educational publisher Pearson, which is currently down almost 10 per cent since the turn of the year, was lifted as JP Morgan Cazenove hiked its target price for the stock to 740p from 671p.

“A strong economic environment and a boost from hurricane clear-up activity provide the backdrop to Ashtead's Q2/H1 results. Management continues to execute a clear strategy and the business is supported by a strong balance sheet providing significant flexibility. Additionally, US tax cuts now appear closer to becoming a reality, providing a potential boost to earnings and economic stimulus.”

Going the other way, Babcock International was on the back foot as it went ex-dividend, while miners Rio Tinto and BHP Billiton retreated as copper and iron prices fell.

Costa and Premier Inn owner Whitbread slipped, giving back some gains made in the previous session when it emerged that US activist investor Sachem Capital had bought a stake in the group.

Risers

BT Group (BT.A) 263.35p 2.39%
Pearson (PSON) 737.50p 2.29%
Vodafone Group (VOD) 228.40p 1.60%
Reckitt Benckiser Group (RB.) 6,649.00p 1.50%
Mediclinic International (MDC) 590.50p 1.46%
Hammerson (HMSO) 507.50p 1.20%
Sky (SKY) 999.00p 1.11%
Ashtead Group (AHT) 1,990.00p 0.96%
International Consolidated Airlines Group SA (CDI) (IAG) 625.00p 0.81%
DCC (DCC) 6,940.00p 0.80%

Fallers

Babcock International Group (BAB) 656.50p -3.17%
Admiral Group (ADM) 1,851.00p -2.22%
Direct Line Insurance Group (DLG) 358.80p -1.70%
Rio Tinto (RIO) 3,439.50p -1.69%
Associated British Foods (ABF) 2,872.00p -1.64%
BAE Systems (BA.) 552.50p -1.52%
GKN (GKN) 293.80p -1.51%
Whitbread (WTB) 3,933.00p -1.43%
BHP Billiton (BLT) 1,323.00p -1.05%
British American Tobacco (BATS) 4,975.50p -1.04%

More news

18:07 Results round-up

Industrial equipment rental firm Ashtead said half year earnings were boosted by clean-up efforts after hurricanes Harvey, Irma and Maria and the weak pound as it posted a 16% rise in pre-tax profits to £493.1m.

18:02 Europe close: Technology and M&A power gains in shares

Stocks on the Continent gained ground on Tuesday paced by Technology issues, even as traders waited on the US central bank's policy announcement the next day.

17:53 London close: Forties failure lifts FTSE as inflation spikes

London stocks extended their gains on Tuesday as supply disruptions boosted the energy sector and investors mulled higher than expected UK inflation figures.

17:33 US open: Boeing, 3M push Dow Industrials to fresh record-high

Wall Street's main indices are again heading higher on Tuesday as the Federal Reserve kicks off its two-day rate-setting meeting and several positive updates from corporate heavyweights such as Boeing and 3M.

17:34 EasyJet acquisition of Air Berlin assets approved by European Commission

UK budget airline easyJet cleared a major regulatory hurdle on Tuesday as its proposed acquisition of airport slots and aircraft from Air Berlin was approved by the European Commission.

17:49 Facebook to overhaul its tax structure worldwide

Facebook will move its global tax and revenue base from Ireland and begin booking advertising locally in every country where it operates.

16:51 GSK given green light for Churg-Strauss syndrome treatment

GlaxoSmithKline has been given approval by the US drug regulator for a first targeted treatment for eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome.

16:44 Trump accuses Democrats of plot after sexual harassment claims

US President Donald Trump has claimed Democrats are behind a series of sexual harassment claims made against him this week.

16:41 Trump vows to send American astronauts to the moon

Donald Trump, the President of the United states signed the Space Policy Directive 1 to send astronauts to the moon again and to Mars for the first time in history.

16:33 Goldman Sachs keeps Barclays and Lloyds at 'sell'

Goldman Sachs reiterated its 'sell' recommendation on shares of Lloyds and Barclays, placing both stocks on its list of 'UK Sell Ideas' for 2018.